Wharton, S., le Roux, C. W., Kosiborod, M. N., Platz, E., Brückmann, M., Jastreboff, A. M., . . . Kaplan, L. M. (2025). Survodutide for treatment of obesity: Rationale and design of two randomized phase 3 clinical trials (SYNCHRONIZE-1 and -2) : clinical trials and investigations. Obesity, 33(1), . https://doi.org/10.1002/oby.24184
Chicago-Zitierstil (17. Ausg.)Wharton, Sean, et al. "Survodutide for Treatment of Obesity: Rationale and Design of Two Randomized Phase 3 Clinical Trials (SYNCHRONIZE-1 and -2) : Clinical Trials and Investigations." Obesity 33, no. 1 (2025). https://doi.org/10.1002/oby.24184.
MLA-Zitierstil (9. Ausg.)Wharton, Sean, et al. "Survodutide for Treatment of Obesity: Rationale and Design of Two Randomized Phase 3 Clinical Trials (SYNCHRONIZE-1 and -2) : Clinical Trials and Investigations." Obesity, vol. 33, no. 1, 2025, https://doi.org/10.1002/oby.24184.